XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Stockholders' Equity Attributable to Parent, Beginning Balance $ (3,133,373)  
Stockholders' Equity Attributable to Parent, Ending Balance (4,442,976) $ (3,133,373)
Shares acquired from ESOP 1,590 4,773
NET LOSS (1,208,003) (784,073)
Total stockholders' deficiency (4,442,976) (3,133,373)
Preferred Stock    
Stockholders' Equity Attributable to Parent, Beginning Balance 20,860 20,860
Stockholders' Equity Attributable to Parent, Ending Balance 20,860 20,860
Total stockholders' deficiency 20,860 20,860
Common Stock    
Stockholders' Equity Attributable to Parent, Beginning Balance 39,052 39,052
Stockholders' Equity Attributable to Parent, Ending Balance 39,052 39,052
Total stockholders' deficiency 39,052 39,052
Additional Paid-in Capital    
Stockholders' Equity Attributable to Parent, Beginning Balance 35,643,373 35,757,201
Stockholders' Equity Attributable to Parent, Ending Balance 35,526,362 35,643,373
Adjustments to Additional Paid in Capital, Other (117,011) (113,828)
Total stockholders' deficiency 35,643,373 35,643,373
Unearned ESOP Shares    
Stockholders' Equity Attributable to Parent, Beginning Balance (3,320,875) (3,439,476)
Stockholders' Equity Attributable to Parent, Ending Balance (3,202,274) (3,320,875)
Shares acquired from ESOP 118,601 118,601
Total stockholders' deficiency (3,320,875) (3,320,875)
Retained Earnings    
Stockholders' Equity Attributable to Parent, Beginning Balance (35,370,272) (34,484,599)
Stockholders' Equity Attributable to Parent, Ending Balance (36,679,875) (35,370,272)
Preferred stock dividends (101,600) (101,600)
NET LOSS (1,208,003) (784,073)
Total stockholders' deficiency (35,370,272) (35,370,272)
Treasury Stock    
Stockholders' Equity Attributable to Parent, Beginning Balance (145,511) (140,738)
Stockholders' Equity Attributable to Parent, Ending Balance (147,101) (145,511)
Shares acquired from ESOP (1,590) (4,773)
Total stockholders' deficiency $ (145,511) $ (145,511)